Search with one or more keywords


This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.


xml
XML

Export to XML

Please choose the format :

pdf
PDF

Export to PDF

Which version do you want to export ?

csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

ARCHIVES : 309 forms

Sorting of results :

POLA - Longitudinal Study on Age-Related Eye Diseases

Head : Delcourt Cécile, Centre de Recherche Inserm U897 "Epidémiologie et Biostatistiques"

Version 3
Overview

73

Last update : 09/05/2017

ARCHIVE

POLA - Longitudinal Study on Age-Related Eye Diseases

Head : Delcourt Cécile, Centre de Recherche Inserm U897 "Epidémiologie et Biostatistiques"

Main objective

To investigate risk factors of age-related eye diseases (Age-Related Macular Degeneration (AMD), cataracts)

Inclusion criteria

Elderly people over 60 years of age living in Sète (Hérault)

PROXAIR - Etude de PROXimologie dans l’Asthme persIstant sévèRe

Head : Ponthieux Anne, Direction Relations Économiques et Institutionnelles

Version 1
Overview

74

Last update : 09/05/2017

ARCHIVE

PROXAIR - Etude de PROXimologie dans l’Asthme persIstant sévèRe

Head : Ponthieux Anne, Direction Relations Économiques et Institutionnelles

Main objective

Assess physical, psychic and socio-economic impact on patients and spouse of severe persistent asthma treated with high-dose inhaler steroids and long-acting ß2 agonists (LABA), according to the asthma control level

Inclusion criteria

Patient inclusion Criteria :
- Ambulatory patients, able to cooperate, of either sex, at least 18 years of age.
- Patients with severe persistent asthma receiving for at least three months a continuous and stable treatment of high-dose inhaler steroids (≥ 1 000 µg/d of beclometasone dipropionate excluding micronized forms in metered-dose inhalers, ≥ 800 µg/d of beclometasone dipropionate in micronized form in metered-dose inhalers or ≥ 800 µg/j of budesonide or ≥ 500 µg/d of fluticasone propionate) and of inhaled long-acting ß2 agonists, administered:
either in the form of two specialties using one or two of the following inhalers: Aerolizer®, standard metered-dose inhaler, Autohaler, Diskus®, Turbuhaler®,
or in the form of a fixed association using one of the following inhalers: standard metered-dose inhaler, Diskus®, Turbuhaler®.
- Patients with FEV measurement in the previous month.
- Patients who brought their inhaled steroid treatment and inhaled long-acting ß2-agonist at the time of consultation.
- Patients in couple whether or not married
- Patients and relatives agree to participate

Patient non-inclusion Criteria :
- Patients with a non-asthmatic OCPD.
- Patients who had inhaled steroids or lLABA treatment change in the previous three months (add-on or change of drug, posology change).
- Patients and relatives refusing to participate to the study
- Parents/ those close unable to complete a self-questionnaire.
- Patients who do not live as a couple

- Cross-sectional study of the influence of exposure to glycol ethers on semen quality

Head : Multigner Luc, Inserm U625

Version 1
Overview

75

Last update : 10/20/2017

ARCHIVE

- Cross-sectional study of the influence of exposure to glycol ethers on semen quality

Head : Multigner Luc, Inserm U625

Main objective

To research the effect of past and current exposure to glycol ethers on semen quality.

Inclusion criteria

- homme
- âgé entre 20 et 55 ans
- employé de la ville de Paris
- n’ayant pas de facteurs de risque d’infertilité

ESCAL - Survey on Health and Eating Behaviours in Martinique

Head : Quénel Philippe, Directeur du LERES - IRSET U1085 Inserm

Version 1
Overview

76

Last update : 09/05/2017

ARCHIVE

ESCAL - Survey on Health and Eating Behaviours in Martinique

Head : Quénel Philippe, Directeur du LERES - IRSET U1085 Inserm

Main objective

The initial objectives of the health and eating habits survey were to identify: - The frequency of major diseases or their risk factors that affect the population of Martinique; - The nutritional status of the population and food intake in relation to potential risk factors; - Population habits in terms of food choices and frequency of consumption; - the population's habitual access to food.

Inclusion criteria

- 3 years and over - living in Martinique for 12 months preceding the survey and at the time of the survey

ASSESS - Assessment of Systemic Involvement and Progression for Patients with Primary Sjogren's Syndrome

Head : Gottenberg Jacques-Eric, U1109 Immuno-rhumatologie moléculaire

Version 2
Overview

77

Last update : 01/01/2019

ARCHIVE

ASSESS - Assessment of Systemic Involvement and Progression for Patients with Primary Sjogren's Syndrome

Head : Gottenberg Jacques-Eric, U1109 Immuno-rhumatologie moléculaire

Main objective

To prospectively determine for the first time the prevalence and risk factors for systemic complications and lymphoma in primary Sjögren's syndrome.

Inclusion criteria

- Men or women - adults - patients in tertiary centres for autoimmune diseases

ADEOS - Adherence evaluation of osteoporosis treatment

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1
Overview

78

Last update : 01/01/2018

ARCHIVE

ADEOS - Adherence evaluation of osteoporosis treatment

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

Finalize and validate a self-administered instrument developed to evaluate adhesion to the treatment
of postmenopausal osteoporosis

Inclusion criteria

Woman;
Over the age of 50 years;
Patient to whom has been prescribed one of the following osteoporosis treatments in the six months prior to the inclusion starting date:
bisphosphonates, selective estrogen receptor modulators (SERM), or strontium ranelate;
Patient fluent in French and who has the cognitive and functional ability required to complete
the self-questionnaires included in the study on their own;
Informed patient who has given their oral consent to participate in this study

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here